You have 9 free searches left this month | for more free features.

Myelofibrosis

Showing 576 - 600 of 670

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thrombocytopenia, Idiopathic Thrombocytopenic Purpura Trial (Romiplostim)

Completed
  • Thrombocytopenia
  • Idiopathic Thrombocytopenic Purpura
  • Romiplostim
  • (no location specified)
Nov 25, 2013

Anxiety Disorder, Chronic Myeloproliferative Disorders, Depression Trial in New York (pain therapy, psychosocial assessment and

Completed
  • Anxiety Disorder
  • +6 more
  • pain therapy
  • psychosocial assessment and care
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013

Myelofibrosis, Myeloproliferative Disorders, Polycythemia Vera Trial in Australia, United States (SB1518)

Completed
  • Myelofibrosis
  • +3 more
  • Scottsdale, Arizona
  • +5 more
Apr 19, 2012

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in New York (pyroxamide)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 4, 2013

Cancer Trial in Cleveland (forodesine HCl)

Completed
  • Cancer
  • forodesine hydrochloride
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
May 29, 2013

Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI

Terminated
  • Chronic Myeloproliferative Disorders
  • +2 more
  • Bethesda, Maryland
    NIH - Warren Grant Magnuson Clinical Center
Apr 30, 2013

Pulmonary Embolism Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Enoxaparin overlapping with and followed by VKA)

Completed
  • Pulmonary Embolism
  • Rivaroxaban (Xarelto, BAY59-7939)
  • Enoxaparin overlapping with and followed by VKA
  • Little Rock, Arkansas
  • +304 more
Jan 25, 2014

Elevated High-sensitivity C-Reactive Protein (hsCRP) Trial in Worldwide (Rosuvastatin, Placebo)

Terminated
  • Elevated High-sensitivity C-Reactive Protein (hsCRP)
  • Birmingham, Alabama
  • +858 more
Feb 6, 2014

Pulmonary Disease, Chronic Obstructive Trial in Worldwide (tiotropium, )

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Anniston, Alabama
  • +489 more
May 15, 2014

Myeloproliferative Disorders, Leukemia, Lymphoma Trial (aprepitant, ondansetron HCl)

Withdrawn
  • Myeloproliferative Disorders
  • +7 more
  • (no location specified)
Mar 29, 2013

Leukemia, Mantle Cell Lymphoma, Myelofibrosis Trial in Houston (RAD001)

Completed
  • Leukemia
  • +2 more
  • Houston, Texas
    M.D. Anderson Cancer Center
Mar 20, 2012

Diagnostic Imaging Trial in Rouen (Xenetix, Visipaque)

Completed
  • Diagnostic Imaging
  • Rouen, France
    CHU Charles Nicolle
Apr 8, 2013

Chronic Graft-Versus-Host Disease in Undergone Donor Stem Cell

Terminated
  • Cancer
  • polymorphism analysis
  • laboratory biomarker analysis
  • Nashville, Tennessee
  • +2 more
May 11, 2013

COPD Trial in Worldwide (Indacaterol 150 µg, Tiotropium)

Completed
  • Chronic Obstructive Pulmonary Disease
  • Capital Federal, Buenos Aires, Argentina
  • +423 more
Sep 16, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Zion (carboplatin, docetaxel, ifosfamide)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Zion, Illinois
    Midwestern Regional Medical Center
Mar 25, 2013

Studying Fentanyl in Patients With Cancer

Terminated
  • Brain and Central Nervous System Tumors
  • +10 more
  • fentanyl citrate
  • pharmacological study
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 16, 2013

Cancer Trial in Dajeon, Seoul (therapeutic allogeneic lymphocytes)

Completed
  • Cancer
  • therapeutic allogeneic lymphocytes
  • Dajeon, Korea, Republic of
  • +1 more
Mar 25, 2013

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Zion (aldesleukin, recombinant interferon alfa, sargramostim)

Completed
  • Breast Cancer
  • +11 more
  • aldesleukin
  • +2 more
  • Zion, Illinois
    Midwestern Regional Medical Center
Mar 25, 2013

Chronic Myeloproliferative Disorders Trial in Portland (imatinib mesylate)

Terminated
  • Chronic Myeloproliferative Disorders
  • imatinib mesylate
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 1, 2011

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Duarte, Los Angeles, Sacramento (decitabine)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Duarte, California
  • +3 more
Feb 13, 2013

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chicago (tipifarnib)

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • Chicago, Illinois
    University of Chicago Cancer Research Center
Feb 8, 2013

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Houston (decitabine, romidepsin)

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • Houston, Texas
    M.D. Anderson Cancer Center at University of Texas
Feb 8, 2013

Cancer Trial in Canada, United States (mycophenolate mofetil, )

Terminated
  • Cancer
  • mycophenolate mofetil
  • placebo
  • Duarte, California
  • +15 more
May 1, 2013